» Articles » PMID: 27254088

Epidemiology of Injection Drug Use: New Trends and Prominent Issues

Overview
Specialty Psychiatry
Date 2016 Jun 3
PMID 27254088
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

After more than 30 years of research, numerous studies have shown that injection drug use is associated with a wide range of adverse health outcomes such as drug overdoses, drug-related suicidal behaviours, comorbid psychiatric disorders, bloodborne pathogens and other infectious diseases, and traumas. This review explores new trends and prominent issues associated with injection drug use. The dynamic nature of injection drug use is underlined by examining its recent trends and changing patterns in Canada and other "high-income countries." Three research topics that could further contribute to the development of comprehensive prevention and intervention strategies aimed at people who inject drugs are also discussed: risk behaviours associated with the injection of prescription opioids, binge injection drug use, and mental health problems as determinants of injection risk behaviours.

Citing Articles

Cognitive Intraindividual variability in injection drug use among Hispanic residents of Puerto Rico.

Chiou K, Feiger J, Snyder R, Davila C, Gocci Carrasco N, Bennett S Appl Neuropsychol Adult. 2024; :1-8.

PMID: 39180514 PMC: 11847948. DOI: 10.1080/23279095.2024.2389564.


Changing the High-Risk Behaviors of Injecting Drug Users in Iran: Application Theory of Planned Behavior.

Jeihooni A, Mohammadkhah F, Bijani M, Afzali Harsini P ScientificWorldJournal. 2024; 2024:4660336.

PMID: 39022182 PMC: 11254463. DOI: 10.1155/2024/4660336.


Septic Arthritis of the Acromioclavicular Joint: A Case Report.

Tally S, Head M, Kraft K J Educ Teach Emerg Med. 2024; 9(1):V9-V14.

PMID: 38344054 PMC: 10854883. DOI: 10.21980/J8VP9N.


The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?.

Hoj S, Minoyan N, Artenie A, Grebely J, Bruneau J Can Liver J. 2022; 1(2):4-13.

PMID: 35990720 PMC: 9202798. DOI: 10.3138/canlivj.1.2.003.


Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: a cross sectional study.

Chiang J, Bluthenthal R, Wenger L, Auerswald C, Henwood B, Kral A BMC Public Health. 2022; 22(1):823.

PMID: 35468819 PMC: 9036752. DOI: 10.1186/s12889-022-13227-4.


References
1.
Golub E, Strathdee S, Bailey S, Hagan H, Latka M, Hudson S . Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007; 91 Suppl 1:S30-8. DOI: 10.1016/j.drugalcdep.2007.02.013. View

2.
Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, ALEXANDER E . Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001; 91(1):42-6. PMC: 1446500. DOI: 10.2105/ajph.91.1.42. View

3.
Craib K, Spittal P, Wood E, Laliberte N, Hogg R, Li K . Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003; 168(1):19-24. PMC: 139313. View

4.
Archibald C, Jayaraman G, Major C, Patrick D, Houston S, Sutherland D . Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methods. AIDS. 2001; 15 Suppl 3:S41-8. DOI: 10.1097/00002030-200104003-00006. View

5.
Havens J, Lofwall M, Frost S, Oser C, Leukefeld C, Crosby R . Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health. 2012; 103(1):e44-52. PMC: 3518360. DOI: 10.2105/AJPH.2012.300874. View